Grant Skrepnek to Insurance Claim Review
This is a "connection" page, showing publications Grant Skrepnek has written about Insurance Claim Review.
Connection Strength
0.044
-
Long-term persistency and costs associated with the use of iron chelation therapies in the treatment of Sickle cell disease within Medicaid programs. J Med Econ. 2013; 16(1):10-8.
Score: 0.026
-
Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions. Med Care. 2007 May; 45(5):456-62.
Score: 0.018